EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

被引：0
|
作者：
Karelkina, E. V. [1 ]
Goncharova, N. S. [1 ]
Simakova, M. A. [1 ]
Moiseeva, O. M. [1 ]
机构：
[1] FGBU Natl Med Res Ctr, St Petersburg, Russia
来源：
KARDIOLOGIYA | 2020年 / 60卷 / 04期
关键词：
PROSTACYCLIN-RECEPTOR AGONIST;
D O I：
10.18087/cardio.2020.4.n1026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：36 / 42
页数：6
相关论文
共 50 条
  • [21] Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
    Grossman, Madeline
    Walker, Stephen
    Ramsey, E. Zachary
    [J]. PEDIATRIC CARDIOLOGY, 2024,
  • [22] Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension
    Bruderer, Shirin
    Hurst, Noemie
    Remenova, Tatiana
    Dingemanse, Jasper
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 743 - 751
  • [23] SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - AN UPDATED META-ANALYSIS
    Azevedo, Taina
    Armelin, Larissa
    Pereira, Jussara
    Gauza, Mateus De Miranda
    Fernandes, Amanda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1903 - 1903
  • [24] Selexipag in the management of pulmonary arterial hypertension: an update
    Coghlan, J. Gerry
    Picken, Christina
    Clapp, Lucie H.
    [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2019, 11 : 55 - 64
  • [25] INDIRECT TREATMENT COMPARISON AND COSTMINIMIZATION ANALYSIS OF RIOCIGUAT VERSUS SELEXIPAG IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Ornstova, E.
    Tuzil, J.
    Chadimova, K.
    Mlcoch, T.
    Dolezal, T.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S111 - S111
  • [26] Single Center Experience In Transitioning Pulmonary Arterial Hypertension Patients From Intravenous Epoprostenol To Oral Selexipag
    Safdar, Z.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [28] Early Canadian Experience Using Selexipag as Part of an Oral Triple Therapy Regimen in Pediatric Patients With Severe Pulmonary Arterial Hypertension
    Averin, Konstantin
    Richards, Susan
    Vorhies, Erika
    Bates, Angela
    [J]. CIRCULATION, 2019, 140
  • [29] An evaluation of selexipag for the treatment of pulmonary hypertension
    Panagiotidou, Evangelia
    Boutou, Afroditi
    Pitsiou, Georgia
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 29 - 36
  • [30] BUDGET-IMPACT OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Bilir, S. P.
    Beaudet, A.
    Zervoudaki, A.
    Lamprou, C.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A641 - A642
12345